Product catalogue
Every compound held in the RSSE catalogue, with its CAS number, molecular formula and structure where available. Certificate of analysis issued per lot; quoted per enquiry.
1,409,276 products · 23488 pages
Products in this list
-
WIN 55212 Impurity 40
BACK ORDERRS-Z397P3K -
Tradipitant Impurity 29
BACK ORDERRS-Z397P3L -
Dexetimide Impurity 118
CUSTOM SYNTHESISRS-Z397P3M -
Ezlopitant Impurity 43
CUSTOM SYNTHESISRS-Z397P3N -
PF 0243873 Impurity 49
BACK ORDERRS-Z397P3O -
Bitolterol Impurity 44
CUSTOM SYNTHESISRS-Z397P3P -
Encaleret Impurity 165
BACK ORDERRS-Z397P3Q -
Apadenoson Impurity 28
BACK ORDERRS-Z397P3R -
Salmefamol Impurity 49
BACK ORDERRS-Z397P3S -
PD 153035 Impurity 126
IN STOCKRS-Z397P3T -
Ethyl 2-Oxo-3-butenoate
IN STOCKRS-Z397P3U -
hypodematine
IN STOCKRS-Z397P3V -
1,3-Cyclohexanedione, 2-acetyl-4-methyl-(9CI)
IN STOCKRS-Z397P3W -
RG-12525 Impurity 56
BACK ORDERRS-Z397P3X -
CS 003 Impurity 158
CUSTOM SYNTHESISRS-Z397P3Y -
Ethyl Pyruvate 3-Nitrophenylhydrazone
CUSTOM SYNTHESISRS-Z397P3Z -
GW 0742 Impurity 31
CUSTOM SYNTHESISRS-Z397P40 -
2,2'-(6,7-Dimethoxyquinazoline-2,4-diyl)bis(hydrazinecarbothioamide)
IN STOCKRS-Z397P41 -
2-(2-(Ethylamino)-6,7-dimethoxyquinazolin-4-yl)hydrazinecarboxamide
IN STOCKRS-Z397P42 -
2-Benzyloctahydro-2H-pyrazino[1,2-a]pyrazine
CUSTOM SYNTHESISRS-Z397P43 -
LY 294002 Impurity 87
BACK ORDERRS-Z397P44 -
ENMD 1068 Impurity 26
BACK ORDERRS-Z397P45 -
Narazaciclib Impurity 240
IN STOCKRS-Z397P46 -
Palovarotene Impurity 259
BACK ORDERRS-Z397P47 -
Elamipretide Impurity 28
BACK ORDERRS-Z397P48 -
CS 003 Impurity 139
CUSTOM SYNTHESISRS-Z397P49 -
2-Methyl-6-isopentyl-5,7-dihydroxychromone
IN STOCKRS-Z397P4A -
2-Methyl-8-isopentyl-5,7-dihydroxychromone
CUSTOM SYNTHESISRS-Z397P4B -
5-Hydroxy-8-isopentyl-7-methoxy-2-methylchromone
IN STOCKRS-Z397P4C -
3,4-Dihydro-5-hydroxy-2,2,8-trimethyl-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one
IN STOCKRS-Z397P4D -
3,4-Dihydro-5-hydroxy-2,2,8-trimethyl-2H,10H-benzo[1,2-b:3,4-b']dipyran-10-one
CUSTOM SYNTHESISRS-Z397P4E -
didocosyl succinate
BACK ORDERRS-Z397P4G -
11-butyldocosane
CUSTOM SYNTHESISRS-Z397P4H -
EICOSANE,9-OCTYL-
IN STOCKRS-Z397P4I -
5-Ethyl-2-MethylHeptane
IN STOCKRS-Z397P4J -
2,2,3,3-tetramethylhexane
CUSTOM SYNTHESISRS-Z397P4K -
N-{(E)-2-[(2,6-Diisopropylphenyl)imino]ethylidene}-2,6-diisopropylaniline
IN STOCKRS-Z397P4M -
Encaleret Impurity 122
BACK ORDERRS-Z397P4N -
A 893 Impurity 64
BACK ORDERRS-Z397P4O -
Giripladib Impurity 22
BACK ORDERRS-Z397P4P -
ethyl 4-isobutylbenzoate
IN STOCKRS-Z397P4Q -
Laropiprant Impurity 88
BACK ORDERRS-Z397P4R -
Avitriptan Impurity 18
BACK ORDERRS-Z397P4S -
Serlopitant Impurity 131
BACK ORDERRS-Z397P4T -
AZD 1283 Impurity 37
BACK ORDERRS-Z397P4U -
Encaleret Impurity 121
CUSTOM SYNTHESISRS-Z397P4V -
Ethyl 2-ethoxy-6-methylbenzoate
IN STOCKRS-Z397P4W -
WIN 55212 Impurity 58
BACK ORDERRS-Z397P4X -
Naxagolide Impurity 63
IN STOCKRS-Z397P4Y -
Apadenoson Impurity 11
IN STOCKRS-Z397P4Z -
Doramapimod Impurity 165
CUSTOM SYNTHESISRS-Z397P50 -
WIN 55212 Impurity 91
BACK ORDERRS-Z397P51 -
Siramesine Impurity 37
BACK ORDERRS-Z397P52 -
Nolasiban Impurity 88
CUSTOM SYNTHESISRS-Z397P53 -
4-(3-BROMOPROPYL)MORPHOLIN-3-ONE
IN STOCKRS-Z397P54 -
Apadenoson Impurity 39
BACK ORDERRS-Z397P55 -
GW 766994 Impurity 20
BACK ORDERRS-Z397P56 -
Palovarotene Impurity 65
BACK ORDERRS-Z397P57
1,409,276 products · 23488 pages






![Chemical structure of 2-Benzyloctahydro-2H-pyrazino[1,2-a]pyrazine](/structures/w4/BDJDGOJLRMBDOS-UHFFFAOYSA-N.webp?v=9)



![Chemical structure of 3,4-Dihydro-5-hydroxy-2,2,8-trimethyl-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one](/structures/w4/IQJZOBSXWBOFSO-UHFFFAOYSA-N.webp?v=9)
![Chemical structure of 3,4-Dihydro-5-hydroxy-2,2,8-trimethyl-2H,10H-benzo[1,2-b:3,4-b']dipyran-10-one](/structures/w4/XGUGFFQRIYSJAS-UHFFFAOYSA-N.webp?v=9)
![Chemical structure of 6,7,8,9-Tetrahydro-5-hydroxy-2,8-dimethyl-4H-pyrano[3,2-h][1]benzoxepin-4-one](/structures/w4/XSGWRNKNCNDJLK-UHFFFAOYSA-N.webp?v=9)






![Chemical structure of N-{(E)-2-[(2,6-Diisopropylphenyl)imino]ethylidene}-2,6-diisopropylaniline](/structures/w4/JWVIIGXMTONOFR-UHFFFAOYSA-N.webp?v=9)


